FDA Drug Recalls

Recalls / Class II

Class IID-1659-2015

Product

Testosterone 200 mg Anastrazole 9 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN

Affected lot / code info
All lots distributed between November 2014 and May 2015; 01292015@32, 7/28/2015; 02232015@18, 5/20/2015; 02272015@31, 8/26/2015; 03092015@23, 9/5/2015; 03272015@32, 9/23/2015

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Recalling firm

Firm
The Compounding Pharmacy of America
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
6216 Highland Place Way Ste 101-A, Knoxville, Tennessee 37919-4068

Distribution

Quantity
94 pellets
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-06-02
FDA classified
2015-09-15
Posted by FDA
2015-09-23
Terminated
2016-02-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1659-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.